SMAD6-deficiency in human genetic disorders

Area of Science:

• Genetics
• Developmental Biology
• Molecular Medicine

Background:

• SMAD6 is an intracellular inhibitor of bone morphogenetic protein (BMP) signaling.
• SMAD6 deficiency is linked to congenital heart disease, craniosynostosis, and radioulnar synostosis.
• Loss-of-function variants in SMAD6 show poor genotype-phenotype correlation, suggesting other factors influence disease presentation.

Purpose of the Study:

• To review clinical and genetic similarities/differences in SMAD6-related disorders.
• To compare Madh6 mouse models and highlight the role of genetic background.
• To elaborate on SMAD6's cellular mechanisms in these developmental disorders.

Main Methods:

• Literature review of clinical and genetic data.
• Comparative analysis of SMAD6-related human conditions.
• Review of Madh6 mouse models and cellular mechanisms.

Main Results:

• Identical SMAD6 variants can lead to diverse phenotypes (cardiovascular, craniosynostosis, radioulnar synostosis).
• Genetic background significantly impacts phenotype expression in SMAD6-related disorders.
• Cellular mechanisms orchestrated by SMAD6 are crucial in the development of these conditions.

Conclusions:

• The pathogenic variant alone does not fully explain the phenotype in SMAD6-related disorders.
• Further research is needed to understand pathogenetic mechanisms.
• Improved understanding will advance molecular diagnosis, therapeutics, and patient counseling.